Skip to main content

and
  1. Article

    CCL-2 as a possible early marker for remission after traumatic spinal cord injury

    Prospective observational study.

    R A Heller, T F Raven, T Swing, K Kunzmann, V Daniel, P Haubruck, M Akbar in Spinal Cord (2017)

  2. Article

    Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury

    A prospective observational study reporting the correlation between matrix metalloprotein serum levels and remission after traumatic spinal cord injury (SCI).

    A Moghaddam, R Heller, V Daniel, T Swing, M Akbar, H-J Gerner, B Biglari in Spinal Cord (2017)

  3. Article

    A pilot study on temporal changes in IL-1β and TNF-α serum levels after spinal cord injury: the serum level of TNF-α in acute SCI patients as a possible marker for neurological remission

    Serum levels of interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) were measured over a 12-week period in 23 patients with spinal cord injury (SCI) with and without neurological improvement.

    B Biglari, T Swing, C Child, A Büchler, F Westhauser, T Bruckner, T Ferbert in Spinal Cord (2015)

  4. Article

    A retrospective study on flap complications after pressure ulcer surgery in spinal cord-injured patients

    A retrospective study reporting specific complications of certain skin flaps for treating pressure ulcers.

    B Biglari, A Büchler, T Reitzel, T Swing, H J Gerner, T Ferbert, A Moghaddam in Spinal Cord (2014)

  5. Article

    Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target

    A pilot study measuring the levels of serum-soluble CD95 ligand (CD95L) in eight spinal cord-injured patients.

    B Biglari, A Büchler, T Swing, E Biehl, H J Roth, T Bruckner, G Schmidmaier in Spinal Cord (2013)